VersaBank reported strong year-over-year growth in Q3, with revenue rising 23% and adjusted net income increasing 27%. The bank's U.S. operations have become a key profit driver, although achieving its ambitious 2027 growth targets will require flawless execution and additional capital. Despite a compressed net interest margin of 2.19%, credit quality remains solid, and management expects margin improvement as the portfolio mix evolves. The stock's valuation is high at 19.15 times forward earnings, but the bank's growth prospects and U.S. momentum support a buy rating.
VersaBank's growth and valuation provide context for financial sector activity on Pluang. For readers following Financials, here is Pluang's market snapshot as of Oct 06, 2026 19:45 WIB: Among 85 priced US Financials stocks, 71 rose and 7 fell today. Deutsche Bank AG (DB) and Aegon Ltd. (AEG) both saw 1.29-1.30% price increases with 100% buy order activity, contrasting with Bit Digital Inc (BTBT) which rose 1.30% but had 69% sell orders and a much shorter typical hold time of 13 days compared to 48-79 days for the others.
Morgan Stanley analyst Bob Huang lowered American International Group's (AIG) price target to $80 from $81, with the stock trading around $76, indicating potential upside. AIG is set to report its Q3 2026 earnings on November 3, with investors focuse...
Vertiv Holdings, a maker of power and cooling equipment for data centers, faces mixed analyst opinions with GLJ Research rating it a "Sell" and BMO Capital giving an "Outperform" rating. Despite a recent stock pullback, the company reported a 241% in...
Apogee Enterprises reported strong fiscal Q2 results with adjusted earnings of $1.17 per share, nearly double the estimated $0.59, and revenue of $391.14 million, surpassing expectations of $362.6 million. This marks a continued trend of beating esti...
McKesson received a bullish price target of $977 from Morgan Stanley, suggesting a 6.7% upside from its current price of $915.45. The company agreed to acquire Option Care Health for $32.05 per share, valuing the deal at approximately $5.8 billion in...
Ameriprise Financial has authorized an additional $5.5 billion for share repurchases through September 2028, supported by $2.1 billion in excess capital and $2.8 billion in liquidity. The company returned $1.9 billion to shareholders in H1 2026, incl...
